SEC Form 4 · accession 0001697955-17-000003
Amarantus Bioscience Holdings, Inc. · AMBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rongguo Wei
Other
Period of report
Nov 3, 2017
Accepted (ET)
Nov 6, 2017 · 11:28 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001424812
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
On May 3, 2017, Mr. Wei resigned as a member of the Board of Amarantus Bioscience Holdings, Inc. On November 3, 2017, Mr. Wei resigned as Chief Financial Officer.